Kodak deal with US government to produce pharmaceuticals appears to be on hold
Photo by Smith Collection/Gado/Getty Images
An agreement between the US government and Kodak to develop generic drug ingredients appears to be on hold, after the US International Development Finance Corporation tweeted that “recent allegations of wrongdoing raise serious concerns.”
“We will not proceed any further unless these allegations are cleared,” the agency tweeted, without specifying what the allegations were.
Kodak said Friday it was conducting an internal review of recent activity by the company in connection with a $765 million loan it would receive under the Defense Production Act to produce pharmaceuticals. The company’s stock price surged in the days before the deal was announced, CBS News reported, leading Sen. Elizabeth Warren (D-MA) to call for the Securities and...
You Might Like
💡 One News Page Knowledge: Other News Mentions
Why Elizabeth Warren Will Never Be Treasury Secretary
Credit: Wochit News Duration: 00:39Published
Sen. Elizabeth Warren Pens Letter to Bob Iger, Bob Chapek Over "Disney’s "Business Decisions" | THR News
Credit: The Hollywood Reporter Duration: 01:33Published
Related videos from verified sources